8/25/2021 8:36:50 AM
Zhongchao Expands Patient Management Business To Ovarian Cancer Market
8/4/2021 7:38:11 AM
Schrdinger And Zai Lab Announce Global R&D Collaboration In Oncology
6/1/2021 7:31:43 AM
Mirati Therapeutics And Zai Lab Collaborate To Develop Adagrasib In Greater China
5/28/2021 7:39:28 AM
Zai Lab Says Dosed First Patient In China In Phase 2 Portion Of TRIDENT-1 Study Of Repotrectinib
4/20/2021 9:54:08 PM
Zai Lab Prices Underwritten Public Offering Of 4.78 Mln ADSs At US$150.00/ADS